Abstract
THALIDOMIDE (alpha-[N-phthalimido]-glutarimide)‡ is a hypnotic frequently prescribed in Europe.1 Investigations in this country are being conducted to evaluate its activity as a daytime sedative and for the treatment of insomnia.2 , 3 Advantages over the commercially available hypnotics are its nontoxicity in animal studies and the low incidence of side effects in the earlier foreign reports. Ayd4 suggests that its nonlethality may make it the hypnotic of choice for potentially suicidal, depressed patients.I have been able to confirm the very satisfactory sleep regulation with thalidomide.5 The case reported below had been a diagnostic problem for months until a recent letter to . . .

This publication has 7 references indexed in Scilit: